Literature DB >> 3091056

Characterization of seven human melanoma cell lines: melanogenesis and secretion of plasminogen activators.

E G Hoal-Van Helden, E L Wilson, E B Dowdle.   

Abstract

Permanent cell lines (UCT-Mel 1 through 7) were established from biopsies of metastatic tissue taken from seven patients with malignant melanoma. Cells from these lines were all aneuploid and all grew as non-contact-inhibited, adherent monolayers. All of the lines, with the remarkable exception of UCT-Mel 6, formed tumours in nude mice, expressed the melanoma M-18 antigen and synthesized plasminogen activators exclusively of the tissue-type. UCT-Mel 6 cells were non tumourigenic, they lacked the M-18 antigen and they synthesized plasminogen activators exclusively of the urokinase type. UCT-Mel 1 and UCT-Mel 2 formed pigment in vitro and both of these lines showed an increase in pigment content and tyrosinase synthesis with increasing cell density. The rate of plasminogen activator released by UCT-Mel 1 and UCT-Mel 3 declined strikingly as the cells became confluent. Assuming that proteolytic activity is required for cell migration in vivo; that tyrosinase synthesis reflects expression of the differentiated phenotype and that melanoma cells retain some of the characteristics of neural crest cells, we suggest that the effects of confluence and close cell-cell contact provide a useful experimental counterpart for the study of normal neural crest all behaviour that is characterized by an inverse relationship between migration and a protease secretion on the one hand and pigmentation on the other.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3091056      PMCID: PMC2001511          DOI: 10.1038/bjc.1986.175

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  24 in total

1.  Characterization of human maligant melanoma cell lines. I. Morphology and growth characteristics in culture.

Authors:  S K Liao; P B Dent; P B McCulloch
Journal:  J Natl Cancer Inst       Date:  1975-05       Impact factor: 13.506

2.  Fluorometric assay of proteins in the nanogram range.

Authors:  P Böhlen; S Stein; W Dairman; S Udenfriend
Journal:  Arch Biochem Biophys       Date:  1973-03       Impact factor: 4.013

3.  Immunological quantitation and immunoadsorption of urokinase-like plasminogen activators secreted by human cells.

Authors:  D Vetterlein; T E Bell; P L Young; R Roblin
Journal:  J Biol Chem       Date:  1980-04-25       Impact factor: 5.157

4.  In vitro plasminogen activator activity in human brain tumors.

Authors:  W S Tucker; W M Kirsch; A Martinez-Hernandez; L M Fink
Journal:  Cancer Res       Date:  1978-02       Impact factor: 12.701

5.  Immunological characterization of multiple weight forms of human cell plasminogen activators.

Authors:  D Vetterlein; P L Young; T E Bell; R Roblin
Journal:  J Biol Chem       Date:  1979-02-10       Impact factor: 5.157

6.  Cell density-dependent secretion of plasminogen activator by 3T3 cells.

Authors:  I N Chou; S P O'Donnell; P H Black; R O Roblin
Journal:  J Cell Physiol       Date:  1977-04       Impact factor: 6.384

7.  Human neoplastic and normal cells in tissue culture. I. Cell lines derived from malignant melanomas and normal melanocytes.

Authors:  B C Glovanella; J S Stehlin; C Santamaria; S O Yim; A C Morgan; L J Williams; A Leibovitz; P J Fialkow; D M Mumford
Journal:  J Natl Cancer Inst       Date:  1976-06       Impact factor: 13.506

8.  Biological properties of human melanoma cells in culture.

Authors:  A A Creasey; H S Smith; A J Hackett; K Fukuyama; W L Epstein; S H Madin
Journal:  In Vitro       Date:  1979-05

9.  Secretion of plasminogen activator by normal, reactive and neoplastic human tissues cultured in vitro.

Authors:  E L Wilson; E Dowdle
Journal:  Int J Cancer       Date:  1978-10-15       Impact factor: 7.396

10.  A study of proteases and protease-inhibitor complexes in biological fluids.

Authors:  A Granelli-Piperno; E Reich
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

View more
  7 in total

1.  Limitations of the quantitative cytochemical assay of catechol oxidase in melanoma cells.

Authors:  A C Croce; G Bottiroli; E Prosperi; R Supino; P J Stoward
Journal:  Histochem J       Date:  1988-11

2.  Plasminogen activation by t-PA on the surface of human melanoma cells in the presence of alpha 2-macroglobulin secretion.

Authors:  J Bizik; A Lizonová; R W Stephens; M Grófová; A Vaheri
Journal:  Cell Regul       Date:  1990-11

3.  Accurate molecular detection of melanoma nodal metastases: an assessment of multimarker assay specificity, sensitivity, and detection rate.

Authors:  V Davids; S H Kidson; G S Hanekom
Journal:  Mol Pathol       Date:  2003-02

4.  Establishment and characterization of a clear-cell sarcoma (malignant melanoma of soft parts) cell line.

Authors:  T Takenouchi; K Ito; T Kazama; M Ito
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

Review 5.  Mechanisms of differentiation in melanoma cells and melanocytes.

Authors:  D C Bennett
Journal:  Environ Health Perspect       Date:  1989-03       Impact factor: 9.031

6.  Unusual growth characteristics of human melanoma xenografts in the nude mouse: a model for desmoplasia, dormancy and progression.

Authors:  M F Gartner; C Fearns; E L Wilson; J A Campbell; E B Dowdle
Journal:  Br J Cancer       Date:  1992-04       Impact factor: 7.640

7.  The proliferation of malignant melanoma cells could be inhibited by ranibizumab via antagonizing VEGF through VEGFR1.

Authors:  Jiao Li; Yan Cui; Qin Wang; Dadong Guo; Xuemei Pan; Xingrong Wang; Hongsheng Bi; Wei Chen; Zhengfeng Liu; Shengya Zhao
Journal:  Mol Vis       Date:  2014-05-13       Impact factor: 2.367

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.